Siirry suoraan sisältöön
Kirjoita hakusana...
Lyhyesti suomeksi
Contact Us
Home
Investors
Why Invest?
Reports and presentations
Corporate Governance
Articles of Association
General Meetings
Board of Directors
Management
Auditor
Press Releases
Investor Relations
Technology
Traumatic Brain Injury
Biomarker R&D program
Proof of concept
Second clinical study
Third clinical study
Assay development plan
Drug development program
IP Rights
Company Profile
Letter From Our CEO
Business Strategy
Board of Directors
Management
Team
News & Events
Press Releases
Lehdistötiedotteet
Articles
Videos
Kirjoita hakusana...
Contact Us
Lyhyesti suomeksi
Valikko
Valikko
Home
Investors
Why Invest?
Reports and presentations
Corporate Governance
Articles of Association
General Meetings
Board of Directors
Management
Auditor
Press Releases
Investor Relations
Technology
Traumatic Brain Injury
Biomarker R&D program
Proof of concept
Second clinical study
Third clinical study
Assay development plan
Drug development program
IP Rights
Company Profile
Letter From Our CEO
Business Strategy
Board of Directors
Management
Team
News & Events
Press Releases
Lehdistötiedotteet
Articles
Videos
Research and Development
Assay development plan
A two-year R&D plan for development of the diagnostic kit
